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abstract
 
Rod photoreceptor cyclic nucleotideÐgated (CNG) channels are modulated by tyrosine phosphoryla-
tion. Rod CNG channels expressed in 
 
Xenopus 
 
oocytes are associated with constitutively active protein tyrosine ki-
nases (PTKs) and protein tyrosine phosphatases that decrease and increase, respectively, the apparent affinity of
the channels for cGMP. Here, we examine the effects of genistein, a competitive inhibitor of the ATP binding site,
on PTKs. Like other PTK inhibitors (lavendustin A and erbstatin), cytoplasmic application of genistein prevents
changes in the cGMP sensitivity that are attributable to tyrosine phosphorylation of the CNG channels. However,
unlike these other inhibitors, genistein also slows the activation kinetics and reduces the maximal current through
CNG channels at saturating cGMP. These effects occur in the absence of ATP, indicating that they do not involve
inhibition of a phosphorylation event, but rather involve an allosteric effect of genistein on CNG channel gating.
This could result from direct binding of genistein to the channel; however, the time course of inhibition is surpris-
ingly slow (
 
.
 
30 s), raising the possibility that genistein exerts its effects indirectly. In support of this hypothesis, we
find that ligands that selectively bind to PTKs without directly binding to the CNG channel can nonetheless de-
crease the effect of genistein. Thus, ATP and a nonhydrolyzable ATP derivative competitively inhibit the effect of
genistein on the channel. Moreover, erbstatin, an inhibitor of PTKs, can noncompetitively inhibit the effect of
genistein. Taken together, these results suggest that in addition to inhibiting tyrosine phosphorylation of the rod
CNG channel catalyzed by PTKs, genistein triggers a noncatalytic interaction between the PTK and the channel
that allosterically inhibits gating.
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introduction
 
Cyclic nucleotideÐgated (CNG)
 
1
 
 channels play a cen-
tral role in both visual and olfactory sensory transduc-
tion. CNG channels are directly activated by the bind-
ing of cyclic nucleotides to the channel protein. Recent
studies show that the sensitivity of CNG channels to cy-
clic nucleotides is not fixed, but rather can be modu-
lated by other cellular factors. Transition metals (Ilde-
fonse and Bennett, 1991; Karpen et al., 1993; Gordon
and Zagotta, 1995), diacylglycerol analogues (Gordon
et al., 1995b), and the local anesthetic tetracaine
(Fodor et al., 1997a,b) all bind to rod photoreceptor
CNG channels and alter their apparent affinity for
cGMP. In addition, Ca
 
2
 
1
 
 modulates the sensitivity of
CNG channels, but it acts in an indirect manner. Thus,
Ca
 
2
 
1
 
 decreases the apparent affinity for cGMP (in-
creases the 
 
K
 
1/2 
 
value) by binding to calmodulin and
other unidentified Ca
 
2
 
1
 
-binding proteins, which then
interact with the CNG channel protein (Hsu and Mol-
day, 1993; Chen et al., 1994; Gordon et al., 1995a).
We have recently shown that rod CNG channels can
also be modulated by tyrosine phosphorylation (Molo-
kanova et al., 1997). Rod CNG channels expressed in
 
Xenopus 
 
oocytes exhibit a spontaneous increase in
cGMP sensitivity after patch excision, and this is re-
versed by application of ATP. These changes in cGMP
sensitivity are blocked by specific inhibitors of protein
tyrosine phosphatases (PTPs) and protein tyrosine ki-
nases (PTKs), respectively. These results imply that the
channel is associated with PTKs and PTPs that remain
active for many minutes after patch excision. Addi-
tional studies (Molokanova Maddox, Luetje, and
Kramer, manuscript submitted for publication) show
that mutagenesis of a specific tyrosine in the 
 
a
 
 subunit
of the rod CNG channel greatly reduces modulation,
suggesting that the crucial phosphorylation site is lo-
cated in the channel protein itself.
In this paper, we study the effects on CNG channels
of genistein, a broad-spectrum PTK inhibitor isolated
from legumes (Akiyama et al., 1987). PTKs have a con-
served binding site for ATP and an additional distinct
site for binding of their protein substrate (Ullrich and
Schlessinger, 1990). Genistein is a competitive inhibi-
tor with respect to ATP in the kinase reaction and a
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noncompetitive inhibitor with respect to the peptide
substrate, suggesting that genistein specifically interacts
with the ATP-binding site. Several other proteins that
possess ATP-binding sites are similarly influenced by
genistein. Thus, genistein competes for ATP-binding
sites on histidine kinase (Huang et al., 1992) and topoi-
somerase II (Markovits et al., 1989), inhibiting these
enzymes, and on the cystic fibrosis transmembrane con-
ductance regulator, potentiating activation of this ion
channel (Weinreich et al., 1997; Wang et al., 1998).
This paper shows that genistein inhibits the rod
CNG channel, above and beyond its inhibitory effect
on tyrosine phosphorylation. The simplest explanation
for this inhibition would involve a direct binding of
genistein to the CNG channel. However, unlike all of
the established direct targets for genistein action, CNG
channels do not appear to contain ATP binding sites.
Examination of the amino acid sequence of the rod
channel 
 
a
 
 subunit does not reveal conserved ATP-
binding domains (Kaupp et al., 1989), and the only
known physiological effects of ATP on CNG channels
occur through its participation in phosphorylation re-
actions (Molokanova et al., 1997). Hence, we have con-
sidered the possibility that genistein does not bind
directly to the channel, but rather acts indirectly by
binding to an accessory protein that then binds to the
CNG channel. Since our previous studies indicate that
the expressed CNG channel is closely associated with
PTKs, we considered the possibility that genistein in-
hibition involves a noncatalytic effect of the PTK. Re-
markably, we observe that the effect of genistein on
the channel is suppressed by erbstatin, another PTK
inhibitor, and by a nonhydrolyzable ATP analogue,
suggesting that the receptor for genistein that medi-
ates inhibition of the rod CNG channel is indeed a
PTK. Hence, we propose that PTKs affect rod CNG
channels in two ways: (a) by allosterically regulating
channel gating, and (b) by catalyzing phosphorylation
of the channel protein.
 
materials and methods
 
Expression and Recording from Rod CNG Channels Expressed 
in Xenopus Oocytes
 
A cDNA clone encoding the bovine rod photoreceptor CNG
channel 
 
a
 
 subunit (Kaupp et al., 1989) was used for in vitro tran-
scription of mRNA, which was injected into 
 
Xenopus
 
 oocytes (50 nl
per oocyte at 1 ng/nl). After 2Ð7 d, the vitelline membrane was
removed from injected oocytes, which were then placed in a
chamber for patch clamp recording at 21Ð24
 
8
 
C. Glass patch pi-
pettes (2Ð3 M
 
V
 
) were filled with a solution containing 115 mM
NaCl, 5 mM EGTA, 1 mM EDTA, and 10 mM HEPES, pH 7.5,
NaOH. This also served as the standard bath solution and cGMP
perfusion solution. EDTA was not included in solutions contain-
ing the Mg
 
2
 
1
 
 salt of ATP or its analogues. After formation of a gi-
gaohm seal, inside-out patches were excised and the patch pi-
pette was quickly (
 
,
 
30 s) placed in the outlet of a 1-mm diame-
ter tube for application of cGMP and other agents. We used a
perfusion manifold containing up to eight different solutions
that is capable of solution changes within 50 ms. Most patches
contained 100Ð200 channels. To calculate the apparent affinity
of CNG channels to cGMP, a series of four to five cGMP concen-
trations was applied to the patch. Steady state cGMP-activated
currents were normalized to saturating responses and fit to the
Hill equation to determine the apparent affinity (
 
K
 
1/2
 
 value) for
cGMP.
PTK inhibitors (genistein, erbstatin, lavendustin A) were pre-
pared as concentrated stock solutions in water or DMSO, and
aqueous solutions containing the final concentrations were pre-
pared for use as needed. The final concentration of DMSO did
not exceed 0.1%, which had no effect on CNG channels or their
modulation. Cyclic GMP, ATP, and AMP-PNP were purchased
from Sigma Chemical Co., genistein, daidzein, erbstatin (stable
analogue), and lavendustin A were purchased from Alexis Corp. 
Current responses through CNG channels were obtained with
an Axopatch 200A patch clamp (Axon Instruments), digitized,
stored, and later analyzed on a 486 PC using pClamp 6.0 soft-
ware. Membrane potential was held at 
 
2
 
75 mV in all experi-
ments. Current responses were normalized to the maximal CNG
current (
 
I
 
max
 
), elicited by saturating (2 mM) cGMP. Normalized
doseÐresponse curves were fit to the Hill equation: 
 
I
 
/
 
I
 
max
 
 5 
 
1/
[1
 
1
 
(
 
K
 
1/2 
 
/
 
A
 
)
 
N
 
], using a nonlinear least squares fitting routine
(Origin; Microcal Software, Inc.), where 
 
A
 
 is the cGMP concen-
tration and 
 
N
 
 is the Hill coefficient. To estimate the 
 
K
 
i
 
 for
genistein, we used a modified Hill equation: 
 
I
 
b
 
/
 
I
 
max
 
 
 
5 
 
[1 
 
2
 
(
 
I
 
b(max)
 
/
 
I
 
max
 
)]/[1 
 
1 
 
(
 
K
 
i
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B
 
)
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] 
 
1
 
 
 
I
 
b(max)
 
/
 
I
 
max
 
, where 
 
B
 
 is the con-
centration of blocker, 
 
I
 
b
 
 and 
 
I
 
b(max)
 
 are the currents activated by
saturating cGMP in the presence of a given blocker concentra-
tion, and a saturating blocker concentration, respectively. Vari-
ability among measurements is expressed as mean 
 
6
 
 SEM.
 
Recording from CNG Channels from Rod Outer Segments
 
Water-phase tiger salamanders (
 
Ambystoma tigrinum
 
) maintained
in a temperature-controlled aquarium (16
 
8
 
C) on a 12/12 light/
dark cycle were used in all experiments at the same time of day.
Animals were dark adapted for 1 h and anesthetized in an ice-
cold solution containing 1 g/liter of 2-amino benzoic acid for 20
min before decapitation and removal of eyes under dim red
light. Eyes were placed in saline containing (mM) 155 NaCl, 2.5
KCl, 1 CaCl
 
2
 
, 2 MgCl
 
2
 
, 10 glucose, and 10 HEPES, pH.7.5. Reti-
nas were removed and gently triturated to yield isolated rods or
rod outer segments. Borosilicate glass pipettes (3Ð5 M
 
V
 
) were
filled with standard patch solution (see above) and used to ob-
tain excised inside-out patches from the outer segment.
 
results
 
Effect of Genistein and Other PTK Inhibitors on 
CNG Channels 
 
Rod CNG channels expressed in 
 
Xenopus
 
 oocytes are
modulated by changes in tyrosine phosphorylation state,
catalyzed by PTKs and PTPs that are native to the oocyte
membrane (Molokanova et al., 1997). Phosphorylation
lowers the cGMP sensitivity of the channel, whereas de-
phosphorylation increases cGMP sensitivity. Hence, af-
ter a membrane patch is excised from the oocyte, the
channels gradually become dephosphorylated, result-
ing in a dramatic increase in cGMP sensitivity (decrease
in 
 
K
 
1/2
 
). When patches are excised into a solution that 
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contains ATP, there is little spontaneous change in
cGMP sensitivity, apparently because dephosphorylation
by tyrosine phosphatases is balanced by phosphoryla-
tion by PTKs. We have shown that addition of PTK in-
hibitors blocks phosphorylation and shifts this equilib-
rium towards dephosphorylation, resulting in an in-
crease in sensitivity to cGMP (Molokanova et al., 1997).
To learn more about modulation of the rod CNG
channel by PTKs, we examined the effects of genistein,
a broad-spectrum PTK inhibitor. Fig. 1 A shows that
genistein, like two other PTK inhibitors (lavendustin A
and erbstatin), causes an increase in cGMP sensitivity
(decrease in 
 
K
 
1/2
 
) when applied in the presence of
ATP. In the absence of ATP, genistein, like the other
inhibitors, had no effect on cGMP sensitivity, whether it
was applied at 10 (Fig. 1 B) or 1 min (
 
n
 
 5 
 
12; data not
shown) after patch excision. Presumably, when ATP is
absent, the PTK is not enzymatically active, precluding
the inhibitors from affecting the phosphorylation state,
and hence the cGMP sensitivity of the channels.
In contrast to their effects on cGMP sensitivity, laven-
dustin A and erbstatin have no effect on the current
elicited by saturating cGMP. Thus, both in the pres-
ence (Fig. 1 C) and absence (Fig. 1 D) of ATP, these
agents had no effect on the maximal current. However,
genistein does have an effect. Addition of 10 
 
m
 
M
genistein inhibits the maximal current by 
 
z
 
50% in the
presence and by 85% in the absence of ATP. Thus
Figure 1. Comparison of the
effects of PTK inhibitors on
the apparent affinity for cGMP
(K1/2) and maximal current (Imax)
through rod CNG channels. (A)
Effect of PTK inhibitors on the
K1/2 for cGMP in the presence
of ATP. Note that all three in-
hibitors reduce the K1/2 for acti-
vation by cGMP. (B) None of
the inhibitors affected the K1/2
for cGMP in the absence of ATP.
The effect of PTK inhibitors on
K1/2 is consistent with inhibition
of a phosphorylation reaction.
(C) Effect of PTK inhibitors on
the maximal current elicited by
saturating (2 mM) cGMP in the
presence of ATP. Note that
genistein, but not the other in-
hibitors, reduced Imax. (D) Gen-
istein inhibition of maximal cur-
rent is even larger in the absence
of ATP. The effect of genistein
on Imax is inconsistent with inhi-
bition of a phosphorylation re-
action. PTK inhibitor concentra-
tions used in these experiments
were (mM) 10 genistein, 10 lav-
endustin A, and 25 erbstatin. Data
represents mean 6 SEM (n 5 8Ð
12 patches for each protocol). 
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genistein more effectively inhibits maximal current in
the absence than in the presence of ATP. These obser-
vations indicate that genistein, distinct from the other
inhibitors, must do more than simply prevent tyrosine
phosphorylation.
 
Genistein Preferentially Inhibits Closed CNG Channels 
 
We more closely examined the effects of genistein on
the maximal current of rod CNG channels expressed in
 
Xenopus
 
 oocytes. Excised inside-out patches typically
contained hundreds of CNG channels that could be
saturated by application of 2 mM cGMP, generating
large currents that reach steady state within 100 ms
(Fig. 2
 
 
 
A). In the presence of 100 
 
m
 
M genistein, the
steady state current elicited by cGMP was much smaller
(40% of control) and activated over a more complex
time course (Fig. 2
 
 
 
B). A fraction of the total current
(4.5%), labeled Òresidual current,Ó activates over the
normal rapid time course. The remaining current acti-
vates very slowly, with a time course that could be fit
with a single exponential with a time constant of 10.6 s
at 100 
 
m
 
M genistein. The observation that pretreat-
ment with genistein slows activation elicited by cGMP
suggests that genistein can interact with the CNG chan-
nel in its closed state.
Genistein can also inhibit the rod CNG channel after
it has been activated by cGMP (Fig. 2 C). In fact, the
steady state level of inhibition is the same regardless of
the order of application of genistein and cGMP.
Genistein slowly suppresses the saturating current with
a time course that can be fit with a single exponential
with a time constant of 7.3 s. The inhibition of closed
CNG channels also develops slowly (data not shown),
and the time course can be fit with a single exponential
of 8.9 s. The slow time constant of genistein inhibition
suggests that rather than interacting directly with the
channel, genistein may bind to a distinct protein that
can allosterically influence channel gating. Daidzein,
an inactive analogue of genistein (Akiyama et al.,
1987), has no effect on rod CNG channels (Fig. 2 D).
Moreover, we observed no effect of genistein or daid-
zein on rat olfactory CNG channels (Dhallan et al.,
1990) expressed in 
 
Xenopus
 
 oocytes (
 
n
 
 5 
 
10 patches).
To investigate the interaction between genistein and
closed CNG channels, patches were pretreated with var-
ious concentrations of genistein before application of
cGMP, as illustrated in Fig. 2 B. We found that the mag-
nitude of the residual current is inversely related to the
genistein concentration (Fig. 3 A). Therefore, the re-
sidual current appears to reflect the fraction of the
current not blocked by genistein. At saturating concen-
trations of genistein (
 
.
 
100 
 
m
 
M), the residual current
was nearly eliminated, indicating complete inhibition
of closed channels by genistein.
In contrast to its effect on closed channels, genistein
was less effective at inhibiting CNG current once it had
been activated by cGMP (Fig. 3 B). Even at high con-
Figure 2. Genistein slows activation and reduces maximal current through rod CNG channels. (A) Response of rod CNG channels in an
excised patch to saturating (2 mM) cGMP. (B) Response to saturating cGMP after preexposure to 100 mM genistein for 1 min. Inset shows
residual current not inhibited by genistein. (C) Partial inhibition of maximal CNG current activated by saturating cGMP. (D) The inactive
genistein analogue daidzein has no effect on the maximal current. 
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centrations of genistein (e.g., 1 mM), inhibition of
steady state CNG current was incomplete. A compari-
son of the effect of genistein on the nonactivated CNG
channels and the fully activated CNG current for this
experiment is shown in Fig. 3 C. Inhibition of the
closed channel by genistein was complete and had an
apparent 
 
K
 
i
 
 of 4.1 
 
m
 
M, which was determined by mea-
suring the residual current. Inhibition of the fully acti-
vated current by genistein was incomplete, with a 
 
K
 
i
 
 of
72.5 
 
m
 
M, which was determined by measuring the
steady state current in the presence of genistein. These
results suggest that genistein has a much higher affinity
for the closed than for the open CNG channel.
Activation of the rod CNG channel by cGMP involves
distinct ligand binding and channel gating steps. Like
cGMP, cAMP binds to the rod channel, but it is much
less effective at causing channel opening. To distinguish
whether the reduced apparent affinity of genistein in
the presence of cGMP is due to bound ligand per se, or
to the conformational changes associated with channel
opening, we investigated the effect of genistein on
channels exposed to saturating cAMP. In these experi-
ments, genistein was applied to the patch in conjunc-
tion with 20 mM cAMP, which should have saturated
the cyclic nucleotide binding sites. Then, the cAMP was
rapidly replaced with cGMP to measure the residual
current. Our results showed that saturating cAMP had
only a small effect on the apparent affinity of genistein,
much less than that observed with saturating cGMP
(Fig. 3 C).
We also examined the effect of genistein on native
CNG channels from rod outer segments from sala-
mander retina. As we observed for the expressed chan-
nel, application of 100 
 
m
 
M genistein on inside-out
patches containing native channels reduced the magni-
tude of the cGMP-activated current and slowed the acti-
vation kinetics (Fig. 3 D). Thus, even though the native
channel contains 
 
a
 
 and 
 
b
 
 subunits (Kaupp et al., 1989;
Chen et al., 1993; Krschen et al., 1995), it is inhibited
by genistein similarly to the inhibition of the expressed
channel, which contains only 
 
a
 
 subunits.
Our results suggest that genistein is not a competitive
inhibitor of the cyclic nucleotide binding site on the
rod channel. The observation that saturating concen-
trations of genistein incompletely inhibit the steady
state CNG current is consistent with this conclusion.
Figure 3. Closed channels are
more sensitive to genistein inhi-
bition than are activated chan-
nels. (A) Inhibition of closed
channels by preexposure to vari-
ous concentrations of genistein
for 1 min. Closed channels were
activated by application of 2 mM
cGMP. Residual currents at five
different genistein concentrations
are indicated by dotted lines, and
the genistein concentrations are
indicated by letter to the right of
each trace. In A, B, and D, the
letter refers to the genistein con-
centration key. Note that the am-
plitude of the residual current is
inversely proportional to the gen-
istein concentration. (B) Inhibi-
tion of steady state CNG current,
maximally activated by saturating
cGMP (2 mM). The effects of five
different genistein concentrations
are indicated by letter to the right
of each trace. (C) DoseÐinhibi-
tion curves of the effect of gen-
istein on closed (residual current
as in A) and maximally activated
channels (steady state current, as
in B). Continuous curves show
fits of the data to the Hill equa-
tion (see materials and meth-
ods). The asterisk depicts inhibition of current activated by saturating cGMP, after preexposure to genistein (10 mm) in conjunction with
a saturating concentration of cAMP (20 mM). Note that preexposure to cAMP has only a minor effect on genistein inhibition (n 5 6 ex-
periments). (D) Inhibition of native CNG channels from salamander rod outer segments after preexposure to various concentrations of
genistein for 1 min. The effects of four different genistein concentrations are indicated by letter to the right of each trace.50 Indirect Inhibition of Cyclic Nucleotide--gated Channels by Genistein
Moreover, the extent of inhibition does not decrease as
cGMP concentration is increased beyond the level re-
quired to saturate the channel. Hence, inhibition is the
same in the presence of 2 and 20 mM cGMP, both for
low (10 mM) and high (100 mM) concentrations of
genistein (Fig. 4 A). Thus, rather than interfering with
cyclic nucleotide binding, genistein appears to inhibit
the rod CNG channel by allosterically affecting channel
gating. Unlike tetracaine, which elicits a voltage-depen-
dent inhibition of CNG channels by binding within the
pore of the channel, genistein inhibits the rod channel
in a voltage-independent manner (Fig. 4 B).
Adenosine Triphosphates Decrease Genistein Inhibition
The inhibition of CNG current by genistein described
above occurs in the absence of ATP and therefore can-
not involve a phosphorylation reaction. However, we
noticed that ATP reduces the ability of genistein to in-
hibit the channels. Fig. 5 A shows that ATP shifts the
doseÐresponse curve for genistein inhibition to the
right, such that a higher concentration of genistein is
required to inhibit CNG current activation by cGMP.
Analysis of these curves (Fig. 5 B) shows that in the ab-
sence of ATP, the Ki for genistein inhibition of CNG
current activation by cGMP was 4.1 6 0.7 mM, whereas
in the presence of 1 mM ATP, the Ki was shifted to a
higher value (10.6 6 1.3 mM). The Hill coefficient for
genistein inhibition was the same in the presence and
absence of ATP (2.0 6 0.2 and 1.9 6 0.2, respectively).
To determine whether the ability of ATP to alter the Ki
for genistein involves a phosphorylation reaction, we
used a nonhydrolyzable ATP analogue adenylylimido-
diphosphate (AMP-PMP), which cannot be used as a
substrate in phosphorylation reactions, but which does
bind to ATP binding sites in proteins. Like ATP, AMP-
PNP reduced the ability of genistein to inhibit the CNG
current. Addition of AMP-PNP shifted the Ki to 9.3 6
0.9 mM without altering the Hill coefficient.
To further test whether the phosphorylation state of
the CNG channel is important for determining the Ki
for genistein, we examined CNG channels at various
times after patch excision from the oocyte. During first
10 min after patch excision, the sensitivity of rod CNG
channels to cGMP changes dramatically, resulting from
tyrosine dephosphorylation (Molokanova et al., 1997),
probably of the CNG channel protein itself (Molo-
kanova, Maddox, Luetje, and Kramer, manuscript sub-
Figure 4. Genistein inhibition is not competitive with respect to cGMP and is not voltage dependent. (A) Inhibition of steady state CNG
current by 10 and 100 mM genistein. Note that the percent inhibition of the maximal current does not change when cGMP is increased
from 2 to 20 mM. (B) CurrentÐvoltage curves of CNG current activated by saturating cGMP (2 and 20 mM) in the presence and absence of
100 mM genistein. n 5 5Ð8 patches for each experiment.51 Molokanova et al.
mitted for publication). Hence, at 1 min after excision,
a patch is likely to have a greater proportion of phos-
phorylated channels than at 10 min after excision. Fig.
6 shows that the Ki values for genistein at 1 and 10 min
after excision do not differ, suggesting that sensitivity
of the channels to genistein is not strongly dependent
on phosphorylation. 
Since it appears that these effects of ATP on genistein
inhibition do not involve changes in phosphorylation, an
alternate possibility is that ATP competes with genistein
for binding to a common site. We propose that the com-
petition between ATP and genistein concerns the ATP
binding site on the PTK. According to this model,
genistein, rather than having a direct effect on the rod
CNG channel, indirectly regulates gating of the channel
by interacting with this tightly associated protein.
Erbstatin Decreases Genistein Inhibition
To further test whether genistein inhibition of the rod
CNG channel involves an interaction with a PTK, we
used the specific PTK inhibitor erbstatin. Studies have
shown that erbstatin competes with peptide substrates
of PTKs, suggesting that erbstatin binds to a site on the
enzyme that normally binds to target proteins (Umezawa
et al., 1986; Imoto et al., 1987). If the inhibition of the
rod channel by genistein is an indirect effect mediated
by a PTK, then erbstatin, like ATP, should reduce the
effect of genistein.
Fig. 7 A shows the effect of erbstatin on genistein in-
hibition of closed rod CNG channels. In this experi-
ment, genistein was applied on closed CNG channels in
the presence or absence of erbstatin, and the channels
were subsequently activated by cGMP. Without erbsta-
tin present, 100 mM genistein inhibited closed chan-
nels by .95%, resulting in a residual current that was
,5% the magnitude of the maximal CNG current.
With 100 mM erbstatin present, genistein inhibited
closed channels by z80%, with a residual current 20%
of maximal. Group data showing inhibition caused by
different concentrations of genistein with and without
erbstatin is shown in Fig. 7 B. Below saturation, increas-
ing the concentration of genistein from 10 to 100 mm
resulted in increasing inhibition, which was partly sup-
pressed by erbstatin. However, unlike the effect of ATP,
the inhibitory effect of erbstatin could not be overcome
by adding additional supersaturating concentrations
of genistein. Thus, increasing the concentration of
genistein 10-fold further from 100 to 1,000 mM did not
elicit more inhibition in the presence of erbstatin, in-
dicating that the interaction between erbstatin and
genistein is noncompetitive.
The ability of erbstatin to depress the action of
genistein is more dramatic when the CNG channels are
fully activated by cGMP (Fig. 8 A). Genistein inhibition
of fully activated CNG current was reduced from 45.8 6
5.7 to 5.4 6 1.7% by pretreatment with 100 mM erbsta-
tin (Fig. 8 B). The suppression of genistein inhibition
by erbstatin reversed fully after erbstatin was removed
from the superfusion solution.
discussion
Rod CNG channels expressed in Xenopus oocytes ap-
pear to be associated with PTKs and PTPs that are con-
stitutively active in excised patches (Molokanova et al.,
1997). Phosphorylation and dephosphorylation cata-
lyzed by these enzymes alter the apparent affinity of the
channels for cGMP. Recent studies strongly suggest
that the a subunit channel protein itself is the substrate
Figure 5. Competitive effects
of ATP and AMP-PNP on
genistein inhibition. (A) DoseÐ
inhibition curves for genistein
alone (n 5 13), genistein plus
200  mM ATP (n 5 7), and
genistein plus 200 mM AMP-PNP.
Continuous curves show fits to
the Hill equation. (B) Histogram
showing  Ki and Hill coefficient
values for genistein inhibition
curves. Data represents mean 6
SEM for all individual experi-
ments included in A. Note that
ATP and AMP-PNP increase the
Ki for genistein without affecting
the Hill coefficient.52 Indirect Inhibition of Cyclic Nucleotide--gated Channels by Genistein
for phosphorylation, with a specific tyrosine residue
(Y498) in the cytoplasmic carboxyl domain being a par-
ticularly important phosphorylation site (Molokanova,
Maddox, Luetje, and Kramer, manuscript submitted
for publication). Ion channels often exist in tight asso-
ciation with protein kinases and phosphatases, such that
complexes of these proteins remain intact even after re-
constitution into artificial lipid bilayers (Reinhart and
Levitan, 1995). A variety of channels have been found
to be biochemically and functionally associated with
PTKs and PTPs (Prevarskaya et al., 1995; Holmes et al.,
1996; Wang and Salter, 1994; Yu et al., 1997). These ac-
cessory proteins can modulate ion channel activity, both
by catalyzing changes in phosphorylation state (Wang
and Salter, 1994; Aniksztejn et al., 1997) and by alloster-
ically regulating channel gating (Holmes et al., 1996).
Our results suggest that genistein affects rod photo-
receptor CNG channels expressed in Xenopus oocytes in
two ways. First, like other PTK inhibitors, genistein pre-
vents tyrosine phosphorylation of rod CNG channels,
allowing the channels to become dephosphorylated
and more sensitive to cGMP. Second, unlike other PTK
inhibitors, genistein slows activation and reduces the
current elicited by saturating cGMP. This second action
of genistein does not require ATP, and thus cannot in-
volve inhibition of phosphorylation by PTKs.
The observation that genistein slows activation and
reduces the maximal cGMP-elicited current suggests
that genistein stabilizes the CNG channel in a closed
state. At first glance, genistein appears to inhibit the
rod CNG channel through a mechanism similar to that
employed by the local anesthetic tetracaine (Fodor et al.,
1997a). Tetracaine preferentially binds to the closed
channel with an apparent affinity of z10 mM. However,
tetracaine block is rapid (,100 ms) and voltage-depen-
dent. Tetracaine is positively charged and mutagenesis
studies suggest that block involves a direct interaction
with a specific glutamate residue in the pore of the rod
channel (Fodor et al., 1997b). In contrast, genistein in-
hibition is slow and voltage independent. Moreover,
our evidence suggests that rather than binding directly
to the channel, the genistein inhibition is indirect, in-
volving an accessory protein that allosterically affects
the CNG channel.
Figure 6. Effect of genistein on the rod CNG channels at different times after patch excision. Genistein was applied on closed rod CNG
channels at different times after excision from the oocyte, and residual current was measured after application of cGMP. Bar graph repre-
sents mean 6 SEM for five patches at 1 and 10 min after excision. During the first 10 min after excision, the K1/2 for cGMP activation grad-
ually declines (see inset), resulting from tyrosine dephosphorylation (Molokanova et al., 1997). The bar graph shows that channels are
equally sensitive to genistein, independent of phosphorylation state.53 Molokanova et al.
The evidence that genistein inhibits the rod channel
by binding to an accessory protein is indirect, but none-
theless compelling. First, the effect of genistein is in-
hibited in a competitive manner by ATP and AMP-PNP.
There is no evidence that CNG channels possess ATP
binding sites, and ATP itself has no noticeable effect on
CNG channels, other than being a substrate in phos-
phorylation reactions. Thus, if PTK inhibitors are
present, ATP has no effect on the apparent affinity or
maximal current elicited by cGMP (Molokanova et al.,
1997), and does not alter the kinetics of activation or
deactivation (our unpublished observations). In con-
trast, CNG channels expressed in Xenopus oocytes are
closely associated with PTKs and, like all kinases, these
proteins do possess ATP binding sites. Moreover, gen-
istein is known to be a competitive inhibitor of these
binding sites (Akiyama et al., 1987).
Second, the effect of genistein is decreased in a non-
competitive manner by erbstatin. Again, application of
erbstatin in the absence of ATP fails to reveal any direct
effect on the rod channel. In contrast, erbstatin is a
well characterized inhibitor of PTKs. Studies have
shown that erbstatin is a competitive inhibitor with re-
spect to the substrate binding site on PTKs, whereas it
has properties of both a competitive and a noncompet-
itive inhibitor with respect to the ATP binding site (Im-
oto et al., 1987; Posner et al., 1994). Our observation
that erbstatin reduces genistein inhibition of CNG
channels noncompetitively suggests that these two
agents bind to nonoverlapping sites, consistent with
previous observations about the effects of these inhibi-
tors on PTKs.
Third, the onset of genistein inhibition for both the
closed and fully activated rod CNG channel is slower
Figure 7. Effect of erbstatin
on genistein inhibition of closed
channels. (A) CNG current acti-
vated by saturating (2 mM) cGMP
alone (control) or after preexpo-
sure to 100 (a and c) or 1,000 (b
and d) mM genistein. Preexpo-
sure to 100 mM erbstatin, as indi-
cated, partially inhibits the effect
of genistein. (B) Summary data
for genistein inhibition alone
(open bars) and with erbstatin
(filled bars). n 5 5 for each con-
dition.54 Indirect Inhibition of Cyclic Nucleotide--gated Channels by Genistein
than would be predicted from the apparent affinity and
the slow recovery rate. We find that the rod CNG chan-
nels require .60 s to recover from genistein inhibition
(our unpublished observations). If the on rate of gen-
istein  inhibition were diffusion limited, as is the case for
many channel blockers and allosteric regulators, an ap-
parent affinity of genistein of 10 mM would suggest that
the inhibition rate constant should be ,100 ms. The
rate of genistein inhibition is much slower than this
value, consistent with inhibition resulting from an in-
teraction between the channel and a second protein (a
PTK) in the membrane. Despite there being a very
large difference in the apparent affinity and magnitude
of genistein inhibition of closed versus activated chan-
nels, the kinetics of inhibition are similar. This observa-
tion is consistent with the hypothesis that the PTK that
mediates genistein inhibition diffuses in the membrane,
and the on rate of inhibition is determined by the colli-
sion rate between this protein and the CNG channel,
regardless of the state of the channel.
Finally, genistein inhibition of CNG channels is cor-
related with the effect of genistein on PTKs. The appar-
ent affinity of genistein for the rod channel (5Ð80 mM)
is similar to the Ki for inhibition of PTKs (2.6Ð18 mM;
Akiyama et al., 1987; Umezawa et al., 1990). The rod
CNG channel can be modulated by PTK and inhibited
by genistein, whereas the rat olfactory CNG channel
(Dhallan et al., 1990) expressed in oocytes exhibits nei-
ther effect (our unpublished observations). Closed rod
CNG channels are more susceptible to modulation by
tyrosine phosphorylation (Molokanova, Maddox, Luetje,
and Kramer, manuscript submitted for publication)
and are more sensitive to inhibition by genistein, than
are activated channels.
Although many of the physiological effects of gen-
istein, including the inhibition of rod CNG channels
reported here, appear to involve PTKS, there have
Figure 8. Effect of erbstatin on genistein inhibition of maxi-
mally activated channels. (A) Genistein (100 mM) inhibition of
CNG current activated by 2 mM cGMP in the absence and pres-
ence of 100 mM erbstatin. (B) Summary data for genistein inhibi-
tion alone (open bars) and with erbstatin (closed bars). n 5 5Ð8
for each condition.
Figure 9. Schematic diagram of genistein inhibition. (A) The
closed channel is loosely associated with a PTK that can catalyze
phosphorylation, whereas the open channel (B) is not. Genistein
stabilizes the interaction between the PTK and the closed channel,
causing inhibition (C), whereas PTK remains unbound from the
open channel (D). Erbstatin destabilizes the interaction between
the PTK and the channel, decreasing genistein inhibition of the
closed channel (E) and eliminating genistein inhibition of the
open channel (F). Genistein is depicted as a pentagram labeled G,
erbstatin is depicted as an oval labeled E, P represents tyrosine
phosphorylation sites on the channel, and the black squares repre-
sent ligand (cGMP).55 Molokanova et al.
been reports of genistein actions that may not involve
PTKs. It has been proposed that genistein directly
blocks voltage-gated Na1 channels in neurons (Paillart
et al., 1997) and smooth muscle (Kusaka and Sperelakis,
1996), and L-type Ca21 channels in heart (Chiang et
al., 1996; Yokoshiki et al., 1996), in part because the
blocking effect is rapid in onset and reversal and is
mimicked by daidzein, which is an inactive analogue of
genistein that does not inhibit PTKs. In contrast, the in-
hibition of rod CNG channels that we have observed is
slow and is not mimicked by daidzein.
A schematic diagram depicting the action of gen-
istein on closed and open channels is shown in Fig. 9.
The closed channel is loosely associated with a PTK,
which can phosphorylate specific tyrosine residues in
the cyclic nucleotide binding domain (Fig. 9 A),
whereas PTK cannot phosphorylate the open channel
(Molokanova, Maddox, Luetje, and Kramer, manu-
script submitted for publication) (Fig. 9 B). Genistein
(G) indirectly affects CNG channels by binding to the
PTK, causing a conformational change that stabilizes or
alters its interaction with the closed channel (Fig. 9 C).
The apparent affinity and efficacy of genistein inhibi-
tion are higher for the closed channel than for the
open channel (Fig. 9 D). The notion that the PTK
more easily dissociates from the open channel is consis-
tent with our findings showing that activation of the
channel makes it much less susceptible to tyrosine
phosphorylation. Erbstatin binds to the substrate bind-
ing site on PTKs, destabilizing the interaction between
the PTK and the channel. Hence, in the presence of
erbstatin, genistein inhibition is reduced in closed
channels (Fig. 9 E) and eliminated in open channels
(Fig. 9 F). Despite their ability to block the catalytic ac-
tivity of PTKs, these effects of genistein are apparently
noncatalytic, because they do not require ATP. More-
over, phosphorylated and dephosphorylated channels
are equally sensitive to genistein inhibition.
In conclusion, our data suggests that when PTKs are
bound to genistein, they can allosterically influence
gating of the rod channel, independently of their role
in catalyzing phosphorylation. Other PTKs have been
shown to noncatalytically regulate gating of ion chan-
nels (Holmes et al., 1996; Zeng et al., 1998). Our find-
ing that genistein inhibits rod CNG channels, not only
in  Xenopus oocytes but also in rod outer segments,
raises the possibility that the native rod CNG channel is
associated with native rod PTKs. Indeed, our previous
studies have shown that the native rod CNG channel is
modulated by tyrosine phosphorylation (Molokanova
et al., 1997). It is possible that genistein is not the only
factor capable of triggering noncatalytic inhibition of
rod CNG channels; perhaps there are native ligands
that have a similar effect. Hence, genistein inhibition
of rod CNG channels may have a physiological corre-
late that is important for photoreceptor function.
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